牙科生医材料市场－全球产业规模、份额、趋势、机会及预测（按类型、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球牙科生物材料市场预计将从 2025 年的 85.3 亿美元成长到 2031 年的 121.9 亿美元，复合年增长率为 6.13%。

这些生物材料由多种生物相容性合成和天然物质组成，旨在修復受损结构、取代缺牙和再生口腔组织。此市场成长的主要驱动力是全球人口老化导致修復治疗需求增加以及牙周疾病盛行率上升。此外，消费者对美容牙科和美容手术的强劲需求也为行业的持续成长奠定了坚实的基础；这些基本成长要素使该市场区别于昙花一现的技术潮流。

然而，新兴经济体中先进牙科治疗的高成本以及保险覆盖范围的不足，对市场渗透构成了重大挑战。这些经济限制导致大量患者无法获得治疗。儘管面临这些经济压力，牙科产业仍保持强劲势头。根据美国牙医协会（ADA）统计，截至2025年8月，美国消费者牙科支出较年初成长4%，显示市场对耗材密集牙科服务的需求持续强劲。

市场驱动因素

人工植牙和修復方案日益普及是推动该产业发展的关键因素，并显着增加了骨移植材料、屏障膜和骨整合材料的消耗量。随着患者越来越倾向于选择固定修復体而非活动义齿，对具有长期稳定性的先进生物相容性材料的需求也随之飙升。这一趋势在主要行业参与者的业务量中得到了清晰的体现，接受修復治疗的患者数量不断增加。例如，士卓曼集团在2024年年度报告（2025年2月发布）中指出，预计2024年将完成670万例治疗，比上年度增加110万例。患者数量的增长直接推动了用于牙槽骨增量和牙槽窝保存手术的合成材料和异种移植材料需求的增长。

同时，龋齿和牙周疾病发生率的上升确保了治疗量的稳定，从而维持了对修復用复合树脂、黏固剂和再生剂的需求。治疗频率的增加，加上医疗基础设施的改善和病患就医管道的扩大，正推动材料使用量的显着成长。根据英国国家医疗服务体系（NHS）商业服务机构2025年8月发布的报告《NHS牙科统计－英格兰2024-25》，2024-25财年将进行3,500万次治疗，较上一季成长4%。这种经济活动的復苏提振了材料製造商的财务业绩，他们正充分利用对修復治疗的持续需求，例如，Envista Holdings Corporation在2025年第三季的核心销售额达到6.7亿美元，年增9.4%。

市场挑战

与先进牙科治疗相关的成本不断上涨，严重阻碍了优质牙科生物材料的广泛应用。合成骨移植材料、薄膜和修復复合材料的采购价格上涨，使得牙医诊所的营运成本成长幅度远超其成长比例。当保险公司和公共卫生系统的报销率未能相应调整以反映这些不断上涨的投入成本时，牙科专业人士便失去了使用优质生物材料的经济奖励。这种价格敏感性迫使诊所要么自行承担亏损，要么选择更便宜、品质更低的替代品，从而限制了尖端材料的销量，并限制了其在富裕患者群体中的市场渗透。

供应链的通膨压力进一步加剧了这项财务负担，直接侵蚀了维持材料密集产业所需的利润率。随着采购成本的上升，医疗服务成本与可用资金之间的差距不断扩大，导致存货周转停滞不前。根据美国牙医协会 (ADA) 2025 年的一项调查，大多数受访牙科诊所表示，自年初以来，设备和耗材的价格上涨了 5% 以上。材料成本的大幅上涨，而报销额却没有相应增加，这正在降低主要终端用户的购买力，并直接抑制全球牙科生物材料市场的成长。

市场趋势

不断扩展的数位和3D列印材料产品组合正在从根本上改变临床工作流程，使高精度复杂器材的直接製造成为可能。这一趋势的特点是，越来越多的专用生物相容性树脂和热塑性材料被采用，它们能够与CAD/CAM生态系统无缝协作，有效取代传统的模拟印模材料。随着牙科专业人士将效率放在首位，用于隐形矫正器和3D列印义齿的数位化最佳化材料的使用量正在加速增长，促使製造商不断丰富其配方。根据Align Technology于2025年10月发布的2025年第三季财务报告，隐形矫正器的交易量达到647,800套，较去年同期成长4.9%，这显示数位化材料产业在矫正治疗领域持续扩张。

同时，受患者对卓越美观性和无金属修復体的需求推动，市场对高渗透性锆和全瓷修復体的需求正在飙升。这种市场转变加速了瓷製熔附金属（PFM）支架的衰落，取而代之的是兼具高断裂韧性和天然光学特性的整体式材料。口内扫描器的整合进一步促进了这一转变，使数位化印模能够与加工削磨机无缝对接，从而快速生产这些陶瓷修復体。根据Modern Dental Group发布的《2025年中期报告》（2025年8月），该公司主要工厂的数位化修復体产量将达到约457,653件，同比增长24.4%，这反映了市场对铣床陶瓷系统的压倒性偏好。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球牙科生医材料市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（金属生物材料、陶瓷生物材料、聚合物生物材料、金属-陶瓷生物材料、天然生物材料、复合生物材料）
  • 依应用领域（矫正、植入、修復牙科等）
  • 按最终用户划分（牙科医院/牙科诊所、牙体技术所、牙科大学/研究机构、牙科产品製造商）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美牙科生医材料市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲牙科生医材料市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区牙科生医材料市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲牙科生医材料市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲牙科生医材料市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球牙科生医材料市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Institut Straumann AG
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• CRS Holdings, LLC.
• Medtronic PLC
• Henry Schein, Inc.
• Mitsui Chemicals, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Dental Biomaterials Market is projected to expand from USD 8.53 Billion in 2025 to USD 12.19 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 6.13%. These biomaterials consist of a variety of biocompatible synthetic and natural substances designed to repair damaged structures, replace missing teeth, or regenerate oral tissues. The market is primarily propelled by an aging global population requiring restorative care and an increasing prevalence of periodontal disorders. Furthermore, strong consumer preference for aesthetic dental improvements and cosmetic procedures establishes a solid foundation for continued industry growth, distinguishing these fundamental drivers from temporary technological trends.

However, the high cost of advanced dental treatments and insufficient reimbursement coverage in emerging economies pose significant challenges that could hinder broader market adoption. These financial constraints limit accessibility for a large segment of the patient population. Despite these economic pressures, the sector remains resilient; according to the American Dental Association, consumer dental spending in the United States rose by 4% as of August 2025 compared to the beginning of the year, underscoring the sustained demand for material-intensive dental services.

Market Driver

The increasing penetration of dental implants and restorative solutions acts as a vital catalyst for the sector, substantially boosting the consumption of bone grafts, barrier membranes, and osseointegrative substances. As patients increasingly favor fixed prosthetic options over removable dentures, the need for advanced biocompatible materials that offer long-term stability has surged. This trend is evident in the operational scale of key industry players seeing higher patient numbers for replacement therapies. For instance, the Straumann Group reported in its 'Annual Report 2024' (February 2025) that the organization supported 6.7 million smiles in 2024, an increase of 1.1 million patients from the prior year. This rise in patient volume directly drives intensified demand for synthetic and xenogeneic substitutes used in ridge augmentation and socket preservation.

Concurrently, the rising incidence of dental caries and periodontal diseases ensures a steady volume of interventions, maintaining demand for restorative composites, cements, and regeneration agents. As healthcare infrastructure improves and patient access widens, the frequency of treatments fuels substantial material utilization. According to the NHS Business Services Authority's August 2025 report, 'NHS Dental Statistics - England 2024-25', 35 million courses of treatment were delivered during the 2024-25 financial year, a 4% increase from the previous period. This rebound in activity supports the financial performance of material manufacturers, as shown by Envista Holdings Corporation, which achieved third-quarter sales of $670 million in 2025 with 9.4% year-over-year core sales growth, illustrating strong capitalization on these persistent restorative care demands.

Market Challenge

The elevated cost associated with advanced dental treatments creates a severe economic barrier that limits the widespread adoption of premium dental biomaterials. When the acquisition price of synthetic bone grafts, membranes, and restorative composites rises, the operational overhead for dental practices increases disproportionately. If reimbursement rates from insurance providers or state healthcare systems do not adjust to match these rising input costs, dental professionals face financial disincentives to use top-tier biomaterials. This price sensitivity often forces practitioners to absorb the deficit or choose less expensive, lower-quality alternatives, effectively capping the sales volume of advanced materials and restricting market penetration to affluent patient demographics.

This financial strain is further exacerbated by inflationary pressures on the supply chain, which directly erode the profit margins necessary to sustain a material-intensive industry. As procurement costs climb, the gap between the expense of delivering care and available funding widens, leading to stagnated inventory turnover. According to the American Dental Association in 2025, the majority of surveyed dental practices reported that prices for equipment and supplies had increased by more than 5% since the start of the year. This measurable rise in material costs, without a commensurate increase in reimbursement, directly hampers the growth of the Global Dental Biomaterials Market by reducing the purchasing power of primary end-users.

Market Trends

The expansion of digital and 3D-printable material portfolios is fundamentally transforming clinical workflows by enabling the direct fabrication of complex appliances with high precision. This trend is defined by the increasing adoption of specialized biocompatible resins and thermoplastics that operate seamlessly within CAD/CAM ecosystems, effectively replacing traditional analog impression materials. As dental professionals prioritize efficiency, the consumption of these digitally optimized materials for clear aligners and printed prosthetics has accelerated, driving manufacturers to broaden their formulations. According to Align Technology's 'Q3 2025 Financial Results' from October 2025, clear aligner volume increased by 4.9% year-over-year to 647.8 thousand cases, demonstrating the sustained industrial scale of digital material utilization in orthodontic treatments.

Simultaneously, there is a surge in demand for high-translucency zirconia and all-ceramic solutions, driven by patient requirements for superior aesthetics and metal-free restorations. This market shift is accelerating the decline of porcelain-fused-to-metal frameworks in favor of monolithic materials that combine high fracture toughness with natural optical properties. The integration of intraoral scanners further catalyzes this transition, as digital impressions seamlessly interface with milling units to produce these ceramic restorations rapidly. According to the Modern Dental Group's 'Interim Report 2025' (August 2025), the volume of digital solution cases produced at its major facilities increased by 24.4% year-over-year to approximately 457,653 units, reflecting the dominant market preference for millable ceramic systems.

Key Market Players

• Institut Straumann AG
• Geistlich Pharma AG
• Zimmer Biomet Holdings, Inc.
• Danaher Corporation
• Dentsply Sirona, Inc.
• 3M Company
• CRS Holdings, LLC.
• Medtronic PLC
• Henry Schein, Inc.
• Mitsui Chemicals, Inc.

Report Scope

In this report, the Global Dental Biomaterials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dental Biomaterials Market, By Type

• Metallic Biomaterials
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

Dental Biomaterials Market, By Application

• Orthodontics
• Implantology
• Prosthodontics
• Others

Dental Biomaterials Market, By End User

• Dental Hospitals& Clinics
• Dental laboratories
• Dental Academies and Research Institutes
• Dental Product manufacturers

Dental Biomaterials Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dental Biomaterials Market.

Available Customizations:

Global Dental Biomaterials Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dental Biomaterials Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Metal-Ceramic Biomaterials, Natural Biomaterials, Composites Biomaterials)
  • 5.2.2. By Application (Orthodontics, Implantology, Prosthodontics, Others)
  • 5.2.3. By End User (Dental Hospitals& Clinics, Dental laboratories, Dental Academies and Research Institutes, Dental Product manufacturers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Dental Biomaterials Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dental Biomaterials Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Dental Biomaterials Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Dental Biomaterials Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Dental Biomaterials Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dental Biomaterials Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Dental Biomaterials Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Dental Biomaterials Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Dental Biomaterials Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Dental Biomaterials Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Dental Biomaterials Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dental Biomaterials Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Dental Biomaterials Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Dental Biomaterials Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Dental Biomaterials Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Dental Biomaterials Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Dental Biomaterials Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dental Biomaterials Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Dental Biomaterials Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Dental Biomaterials Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Dental Biomaterials Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dental Biomaterials Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Dental Biomaterials Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Dental Biomaterials Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dental Biomaterials Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Institut Straumann AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Geistlich Pharma AG
• 15.3. Zimmer Biomet Holdings, Inc.
• 15.4. Danaher Corporation
• 15.5. Dentsply Sirona, Inc.
• 15.6. 3M Company
• 15.7. CRS Holdings, LLC.
• 15.8. Medtronic PLC
• 15.9. Henry Schein, Inc.
• 15.10. Mitsui Chemicals, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer